BRISTOL-MYERS SQUIBB COMPANY Payment for Pension Benefits
BRISTOL-MYERS SQUIBB COMPANY (BMY) reported Payment for Pension Benefits of $200.00 million for the 3-month period ending 2019-12-31, per its 10-Q filed 2020-11-05.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:PensionContributions · last filed 2020-11-05
- BRISTOL-MYERS SQUIBB COMPANY payment for pension benefits for the quarter ending 2019-12-31 was $200.00M.
- BRISTOL-MYERS SQUIBB COMPANY payment for pension benefits for the quarter ending 2019-09-30 was $1.30B.
- BRISTOL-MYERS SQUIBB COMPANY payment for pension benefits for fiscal 2018 was $71.00M, a 82.07% decline from fiscal 2017.
- BRISTOL-MYERS SQUIBB COMPANY payment for pension benefits for fiscal 2017 was $396.00M, a 388.89% increase from fiscal 2016.
- BRISTOL-MYERS SQUIBB COMPANY payment for pension benefits for fiscal 2016 was $81.00M, a 31.36% decline from fiscal 2015.
- BRISTOL-MYERS SQUIBB COMPANY payment for pension benefits for fiscal 2015 was $118.00M, a 4.84% decline from fiscal 2014.
| Period end | Payment for Pension Benefits 3 month | Payment for Pension Benefits 6 month | Payment for Pension Benefits 12 month |
|---|---|---|---|
| 2019-12-31 | $200.00M 10-Q · filed 2020-11-05 | $1.50B derived: sum of 2 quarters · filed 2020-11-05 | |
| 2019-09-30 | $1.30B 10-Q · filed 2020-11-05 | ||
| 2018-12-31 | $71.00M 10-K · filed 2019-02-25 | ||
| 2017-12-31 | $396.00M 10-K · filed 2019-02-25 | ||
| 2016-12-31 | $81.00M 10-K · filed 2019-02-25 | ||
| 2015-12-31 | $118.00M 10-K · filed 2018-02-13 | ||
| 2014-12-31 | $124.00M 10-K · filed 2017-02-21 | ||
| 2013-12-31 | $251.00M 10-K · filed 2016-02-12 | ||
| 2012-12-31 | $396.00M 10-K · filed 2015-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |